Warning: The NCBI web site requires JavaScript to function. more...
Three-dimensional studies of pathogenic peptides from the c-terminal of Trypanosoma cruzi ribosomal P proteins and their interaction with a monoclonal antibody structural model.
Martín OA, Villegas ME, Aguilar CF.
PMC Biophys. 2009 May 27;2(1):4.
Related citations
A monoclonal antibody against the immunodominant epitope of the ribosomal P2beta protein of Trypanosoma cruzi interacts with the human beta 1-adrenergic receptor.
Mahler E, Sepulveda P, Jeannequin O, Liegeard P, Gounon P, Wallukat G, Eftekhari P, Levin MJ, Hoebeke J, Hontebeyrie M.
Eur J Immunol. 2001 Jul;31(7):2210-6.
Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus.
Kaplan D, Ferrari I, Bergami PL, Mahler E, Levitus G, Chiale P, Hoebeke J, Van Regenmortel MH, Levin MJ.
Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10301-6.
The beta1 adrenergic effects of antibodies against the C-terminal end of the ribosomal P2beta protein of Trypanosoma cruzi associate with a specific pattern of epitope recognition.
Lopez Bergami P, Gómez KA, Levy GV, Grippo V, Baldi A, Levin MJ.
Clin Exp Immunol. 2005 Oct;142(1):140-7.
Structural basis of the cross-reaction between an antibody to the Trypanosoma cruzi ribosomal P2beta protein and the human beta1 adrenergic receptor.
Smulski C, Labovsky V, Levy G, Hontebeyrie M, Hoebeke J, Levin MJ.
FASEB J. 2006 Jul;20(9):1396-406.
Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor.
Ferrari I, Levin MJ, Wallukat G, Elies R, Lebesgue D, Chiale P, Elizari M, Rosenbaum M, Hoebeke J.
J Exp Med. 1995 Jul 1;182(1):59-65.
Searching for new clues about the molecular cause of endomyocardial fibrosis by way of in silico proteomics and analytical chemistry.
Wayengera M.
PLoS One. 2009 Oct 12;4(10):e7420.
Antibodies against the carboxyl-terminal end of the Trypanosoma cruzi ribosomal P proteins are pathogenic.
López Bergami P, Scaglione J, Levin MJ.
FASEB J. 2001 Dec;15(14):2602-12.
Crystal structure of the complex mAb 17.2 and the C-terminal region of Trypanosoma cruzi P2β protein: implications in cross-reactivity.
Pizarro JC, Boulot G, Bentley GA, Gómez KA, Hoebeke J, Hontebeyrie M, Levin MJ, Smulski CR.
PLoS Negl Trop Dis. 2011 Nov;5(11):e1375. Epub 2011 Nov 1.
Correlation between conformation and antibody binding: NMR structure of cross-reactive peptides from T. cruzi, human and L. braziliensis.
Soares MR, Bisch PM, Campos de Carvalho AC, Valente AP, Almeida FC.
FEBS Lett. 2004 Feb 27;560(1-3):134-40.
Trypanosoma cruzi acidic ribosomal P protein gene family. Novel P proteins encoding unusual cross-reactive epitopes.
Skeiky YA, Benson DR, Guderian JA, Sleath PR, Parsons M, Reed SG.
J Immunol. 1993 Nov 15;151(10):5504-15.
Antigens shared by Leishmania species and Trypanosoma cruzi: immunological comparison of the acidic ribosomal P0 proteins.
Skeiky YA, Benson DR, Elwasila M, Badaro R, Burns JM Jr, Reed SG.
Infect Immun. 1994 May;62(5):1643-51.
Immunization with recombinant Trypanosoma cruzi ribosomal P2beta protein induces changes in the electrocardiogram of immunized mice.
Lopez Bergami P, Cabeza Meckert P, Kaplan D, Levitus G, Elias F, Quintana F, Van Regenmortel M, Laguens R, Levin MJ.
FEMS Immunol Med Microbiol. 1997 May;18(1):75-85.
Cloning and expression of Trypanosoma cruzi ribosomal protein P0 and epitope analysis of anti-P0 autoantibodies in Chagas' disease patients.
Skeiky YA, Benson DR, Parsons M, Elkon KB, Reed SG.
J Exp Med. 1992 Jul 1;176(1):201-11.
Functionally active cardiac antibodies in chronic Chagas' disease are specifically blocked by Trypanosoma cruzi antigens.
Masuda MO, Levin M, De Oliveira SF, Dos Santos Costa PC, Bergami PL, Dos Santos Almeida NA, Pedrosa RC, Ferrari I, Hoebeke J, Campos de Carvalho AC.
FASEB J. 1998 Nov;12(14):1551-8.
Structural and functional complexity of the humoral response against the Trypanosoma cruzi ribosomal P2 beta protein in patients with chronic Chagas' heart disease.
Mahler E, Hoebeke J, Levin MJ.
Clin Exp Immunol. 2004 Jun;136(3):527-34.
Emerging issues of connexin channels: biophysics fills the gap.
Harris AL.
Q Rev Biophys. 2001 Aug;34(3):325-472. Review. Erratum in: Q Rev Biophys 2002 Feb;35(1):109.
Preliminary structural studies of the hydrophobic ribosomal P0 protein from Trypanosoma cruzi, a part of the P0/P1/P2 complex.
Ayub MJ, Barroso JA, Levin MJ, Aguilar CF.
Protein Pept Lett. 2005 Aug;12(6):521-5.
Major Trypanosoma cruzi antigenic determinant in Chagas' heart disease shares homology with the systemic lupus erythematosus ribosomal P protein epitope.
Mesri EA, Levitus G, Hontebeyrie-Joskowicz M, Dighiero G, Van Regenmortel MH, Levin MJ.
J Clin Microbiol. 1990 Jun;28(6):1219-24.
Anti-beta1-adrenergic receptor autoantibodies in patients with chronic Chagas heart disease.
Labovsky V, Smulski CR, Gómez K, Levy G, Levin MJ.
Clin Exp Immunol. 2007 Jun;148(3):440-9. Epub 2007 Apr 5.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on